AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial - Reuters
AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxNLXdhaVRKY2VrQnZteVlCd1FjUnpyc2NpYUt5NG0wZERDU0ZraWU5blhMOXBrRWVZWU1vVUZTbE5XaTRpVFFpSEZNV3ZTaDlVTTdHTnkwY1dxcWx2bUpwU0xRS0E0MkNIVFVkYjA1d28zZGxJazh1OGtKTzJWeVE4TWFldTRKMS1FUzVnQ0J5QVpmTW5rQTVwWXREWkk2WkRDTjFOanI2eF9QQ0E0cWtER1Zxd3JHTDBOMkVkSXFQOThoMmlZTHd5Mi1HMWg2b3YtcHp0SVhORFl6b0EtZjZlNnhmaUY?oc=5" target="_blank">AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Merck's drug for diabetes-related eye disease meets trial goal - Reuters
Merck's drug for diabetes-related eye disease meets trial goal Reuters
September 24, 2026 at 02:52 PMUS FDA approves AbbVie's drug for Parkinson's disease - reuters.com
US FDA approves AbbVie's drug for Parkinson's disease reuters.com
September 25, 2026 at 10:57 PMViking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge - Reuters
Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge Reuters
September 22, 2026 at 08:10 PMRoche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial - Reuters
Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial Reuters
September 22, 2026 at 11:25 AMUS FDA advisers endorse Grail cancer test's benefits in key vote - Reuters
US FDA advisers endorse Grail cancer test's benefits in key vote Reuters
September 23, 2026 at 11:03 PMUS FDA approves Mirum's drug for rare bone disorder - reuters.com
US FDA approves Mirum's drug for rare bone disorder reuters.com
September 25, 2026 at 08:11 PM